๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Compound trial record
Trackers Drugs Trial finder
Compound · clinical trials

Prednisone Acetate clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 7 trials in our China, Ireland, UK and USA registers that name Prednisone Acetate as an intervention. Synced 25 Sep 2026
7Current trials
4Recruiting now
5Lead sponsors
4Country registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 โ€” Top 14 finalist
Compiled from ClinicalTrials.gov registry records ยท Last verified ยท Editorial standards
At a glance

Prednisone Acetate is named as an intervention in 7 current clinical trials in our China, Ireland, UK and USA registers. 4 are recruiting patients now. The most common phase is Phase 1/2. The sponsor with the most trials is Jiangsu HengRui Medicine Co., Ltd (3). The most-studied condition is Prostate Cancer.

Trials by status

  • Recruiting457%
  • Not yet open343%

Trials by phase

  • Phase 1/2343%
  • Phase 3114%
  • Phase 2/3114%
  • Phase 2114%
  • Phase 1114%
01

Clinical trials of Prednisone Acetate

7 trials
StudyPhaseStatusLead sponsorRegisters
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650 · ClinicalTrials.gov ↗ · Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Phase 3 Recruiting Merck Sharp & Dohme LLC Ireland, UK, USA, China
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
NCT06568094 · ClinicalTrials.gov ↗ · Prostate Cancer
Phase 1/2 Recruiting Jiangsu HengRui Medicine Co., Ltd. China
A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
NCT06689163 · ClinicalTrials.gov ↗ · Prostate Cancer
Phase 1/2 Recruiting Jiangsu HengRui Medicine Co., Ltd. China
Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT05942001 · ClinicalTrials.gov ↗ · Advanced Prostate Cancer
Phase 1 Recruiting Jiangsu HengRui Medicine Co., Ltd. China
Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus
NCT07814664 · ClinicalTrials.gov ↗ · Systemic Lupus Erthematosus
Phase 2/3 Not yet open Chinese SLE Treatment And Research Group China
A Study of BEBT-908 in Combination With Chemotherapy in Patients With Previously Untreated Peripheral T-Cell Lymphoma (PTCL)
NCT07676175 · ClinicalTrials.gov ↗ · Previously Untreated Peripheral T-Cell Lymphoma
Phase 2 Not yet open BeBetter Med Inc China
A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma
NCT07818499 · ClinicalTrials.gov ↗ · Diffuse Large B-Cell Lymphoma
Phase 1/2 Not yet open Sichuan Baili Pharmaceutical Co., Ltd. China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Prednisone Acetate

7 conditions
Prostate Cancer2Metastatic Castration-resistant Prostate Cancer (mCRPC)1Prostatic Neoplasms1Systemic Lupus Erthematosus1Previously Untreated Peripheral T-Cell Lymphoma1Diffuse Large B-Cell Lymphoma1Advanced Prostate Cancer1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Jiangsu HengRui Medicine Co., Ltd.3
Merck Sharp & Dohme LLC1
Chinese SLE Treatment And Research Group1
BeBetter Med Inc1
Sichuan Baili Pharmaceutical Co., Ltd.1
04

By country register

RegisterTrialsRecruiting
Clinical trials in China74
Clinical trials in Ireland11
Clinical trials in UK11
Clinical trials in USA11

A trial with sites in more than one country appears in each of those registers.

05

Related compounds

06

Questions about Prednisone Acetate trials

How many clinical trials are testing Prednisone Acetate?

7 current trials in our China, Ireland, UK and USA registers name Prednisone Acetate as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.

Are Prednisone Acetate trials recruiting patients?

Yes. 4 of the 7 trials are recruiting: 4 with sites in China, 1 with sites in Ireland, 1 with sites in UK and 1 with sites in USA. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Prednisone Acetate clinical trials?

Jiangsu HengRui Medicine Co., Ltd (3), Merck Sharp & Dohme LLC (1), Chinese SLE Treatment And Research Group (1) and BeBetter Med Inc (1), among 5 lead sponsors in total. The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Prednisone Acetate works or whether it is effective, and it is not medical advice.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records โ€” it is not written from memory, and nothing here describes how Prednisone Acetate works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Prednisone Acetate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician โ€” our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us โ€” we correct promptly and log it.